Neogen Chemicals Intrinsic Value
NEOGEN • Chemicals
Current Stock Price
₹1112.00
Primary Intrinsic Value
₹333.60
Market Cap
₹2891 Cr
-70.0%
Downside
Median Value
₹333.60
Value Range
₹303 - ₹1024
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%
NEOGEN Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹333.60 | ₹266.88 - ₹400.32 | -70.0% | EPS: ₹5.12, Sector P/E: 12x |
| Book Value Method | asset | ₹303.46 | ₹273.11 - ₹333.81 | -72.7% | Book Value/Share: ₹303.46, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹333.60 | ₹300.24 - ₹366.96 | -70.0% | Revenue/Share: ₹324.62, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹444.80 | ₹400.32 - ₹489.28 | -60.0% | EBITDA: ₹128.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1023.97 | ₹819.18 - ₹1228.76 | -7.9% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹333.60 | ₹300.24 - ₹366.96 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹333.60 | ₹300.24 - ₹366.96 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹333.60 | ₹300.24 - ₹366.96 | -70.0% | EPS: ₹5.12, BVPS: ₹303.46 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
NEOGEN Intrinsic Value Analysis
What is the intrinsic value of NEOGEN?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Neogen Chemicals (NEOGEN) is ₹333.60 (median value). With the current market price of ₹1112.00, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹303.46 to ₹1023.97, indicating ₹303.46 - ₹1023.97.
Is NEOGEN undervalued or overvalued?
Based on our multi-method analysis, Neogen Chemicals (NEOGEN) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.44 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 1.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 14.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.48x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Neogen Chemicals
Additional stock information and data for NEOGEN
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹196 Cr | ₹38 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹-29 Cr | ₹-137 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-30 Cr | ₹-78 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹1 Cr | ₹-72 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹84 Cr | ₹17 Cr | Positive Free Cash Flow | 7/10 |